Emergency reversal of anticoagulation: from theory to real use of prothrombin complex concentrates. A retrospective Italian experience. (yeni pencere açar)

Barillari G, Pasca S, Barillari A, De Angelis V.

Kaynak‎: Blood Transfus 2012;10(1):87-94.

İndeks‎: PubMed 22044952

DOI‎: 10.2450/2011.0030-11

https://www.ncbi.nlm.nih.gov/pubmed/22044952 (yeni pencere açar)

Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (yeni pencere açar)

Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, Dunn AS, Kunz R; American College of Chest Physicians.

Kaynak‎: Chest 2012;141(2 Suppl):e326S-50S.

İndeks‎: PubMed 22315266

DOI‎: 10.1378/chest.11-2298

https://www.ncbi.nlm.nih.gov/pubmed/22315266 (yeni pencere açar)

Pharmacological prophylaxis of bleeding in surgical patients treated with aspirin. (yeni pencere açar)

Flordal PA.

Kaynak‎: Eur J Anaesthesiol Suppl 1997;14:38-41.

İndeks‎: PubMed 9088834

https://www.ncbi.nlm.nih.gov/pubmed/9088834 (yeni pencere açar)

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (yeni pencere açar)

Goldstein JN, Refaai MA, Milling TJ Jr, Lewis B, Goldberg-Alberts R, Hug BA, Sarode R.

Kaynak‎: Lancet 2015;385(9982):2077-87.

İndeks‎: PubMed 25728933

DOI‎: 10.1016/S0140-6736(14)61685-8

https://www.ncbi.nlm.nih.gov/pubmed/25728933 (yeni pencere açar)

How I treat warfarin-associated coagulopathy in patients with intracerebral hemorrhage. (yeni pencere açar)

Goodnough LT, Shander A.

Kaynak‎: Blood 2011;117(23):6091-9.

İndeks‎: PubMed 21411756

DOI‎: 10.1182/blood-2010-11-316075

https://www.ncbi.nlm.nih.gov/pubmed/21411756 (yeni pencere açar)

Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P/N): a pharmacovigilance study. (yeni pencere açar)

Hanke AA, Joch C, Görlinger K.

Kaynak‎: Br J Anaesth 2013;110(5):764-72.

İndeks‎: PubMed 23335567

DOI‎: 10.1093/bja/aes501

https://www.ncbi.nlm.nih.gov/pubmed/23335567 (yeni pencere açar)

Reversing the effects of antiplatelet agents in the setting of intracranial hemorrhage: a look at the literature. (yeni pencere açar)

Jaben EA, Mulay SB, Stubbs JR.

Kaynak‎: J Intensive Care Med 2015;30(1):3-7.

İndeks‎: PubMed 25492811

DOI‎: 10.1177/0885066613487298

https://www.ncbi.nlm.nih.gov/pubmed/25492811 (yeni pencere açar)

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (yeni pencere açar)

Levi M, Eerenberg E, Kamphuisen PW.

Kaynak‎: J Thromb Haemost 2011;9(9):1705-12.

İndeks‎: PubMed 21729240

DOI‎: 10.1111/j.1538-7836.2011.04432.x

https://www.ncbi.nlm.nih.gov/pubmed/21729240 (yeni pencere açar)

Emergency reversal of warfarin anticoagulation. (yeni pencere açar)

Lin Y, Callum J.

Kaynak‎: CMAJ 2010;182(18):2004.

İndeks‎: PubMed 21078740

DOI‎: 10.1503/cmaj.100983

https://www.ncbi.nlm.nih.gov/pubmed/21078740 (yeni pencere açar)

Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers. (yeni pencere açar)

Marlu R, Hodaj E, Paris A, Albaladejo P, Cracowski JL, Pernod G.

Kaynak‎: Thromb Haemost 2012;108(2):217-24.

İndeks‎: PubMed 22627883

DOI‎: 10.1160/TH12-03-0179

https://www.ncbi.nlm.nih.gov/pubmed/22627883 (yeni pencere açar)

Recent advances in the development of specific antidotes for target-specific oral anticoagulants. (yeni pencere açar)

Mo Y, Yam FK.

Kaynak‎: Pharmacotherapy 2015;35(2):198-207.

İndeks‎: PubMed 25644580

DOI‎: 10.1002/phar.1532

https://www.ncbi.nlm.nih.gov/pubmed/25644580 (yeni pencere açar)

Idarucizumab for dabigatran reversal - full cohort analysis. (yeni pencere açar)

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

Kaynak‎: N Engl J Med 2017;377(5):431-41.

İndeks‎: PubMed 28693366

DOI‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 (yeni pencere açar)

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (yeni pencere açar)

Skolnick BE, Shenouda M, Khutoryansky NM, Pusateri AE, Gabriel D, Carr ME.

Kaynak‎: Anesth Analg 2011;113(4):703-10.

İndeks‎: PubMed 21890888

DOI‎: 10.1213/ANE.0b013e318228c690

https://www.ncbi.nlm.nih.gov/pubmed/21890888 (yeni pencere açar)

Oral anticoagulation in surgical procedures: risks and recommendations. (yeni pencere açar)

Torn M, Rosendaal FR.

Kaynak‎: Br J Haematol 2003;123(4):676-82.

İndeks‎: PubMed 14616972

https://www.ncbi.nlm.nih.gov/pubmed/14616972 (yeni pencere açar)

Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding. (yeni pencere açar)

Warkentin TE, Margetts P, Connolly SJ, Lamy A, Ricci C, Eikelboom JW.

Kaynak‎: Blood 2012;119(9):2172-4.

İndeks‎: PubMed 22383791

DOI‎: 10.1182/blood-2011-11-393587

https://www.ncbi.nlm.nih.gov/pubmed/22383791 (yeni pencere açar)